Prevalence and Sociodemographic Correlates of Antinuclear Antibodies in the United States
2012.7.16
|
Safety and efficacy of etanercept in a cohort of patients with juvenile idiopathic arthritis under 4 years of age
2012.7.2
|
Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis
2012.6.1
|
Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q
2012.5.14
|
Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study
2012.3.15
|
Efficacy of the Antiphospholipid Score for the Diagnosis of Antiphospholipid Syndrome and Its Predictive Value for Thrombotic Events
2012.2.29
|
Use of Atorvastatin in Systemic Lupus Erythematosus in Children and Adolescents
2012.2.14
|
Corticosteroid Pulse Combination Therapy for Refractory Kawasaki Disease: A Randomized Trial
2012.1.3
|
New Onset of Uveitis During Anti-Tumor Necrosis Factor Treatment for Rheumatic Diseases
2011.11.23
|
Pregnancy Outcomes in Systemic Lupus Erythematosus with and without Previous Nephritis
2011.11.18
|
Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis
2011.11.12
|
Pulmonary outcome in
juvenile dermatomyositis: a case-control study
2011.10.22
|
Clinical Outcomes After Withdrawal of Anti–Tumor Necrosis Factor alpha Therapy in Patients With Juvenile Idiopathic Arthritis: A Twelve-Year Experience
2011.10.22
|
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
2011.09.23
|
Vaccination of children
and adolescents with rheumatic diseases
2011.8.18
|
Juvenile idiopathic
arthritis; ongoing disease activity and changing categories in a long-term
Nordic cohort study
2011.08.09
|
Reduced-Dose Rituximab in
Rheumatoid Arthritis
2011.4.28
|
Antinuclear Antibody–Positive Patients Should Be Grouped as a Separate Category in the Classification of Juvenile Idiopathic Arthritis
2011.03.15
|
Corticosteroids May Improve Clinical Outcomes During Hospitalization for Henoch-Schönlein Purpura
2010.10.28
|
Clinicopathological Characteristics and Outcome of Chinese Patients with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome: A 9-Year Retrospective Study
2010.11.19
|
Corticosteroids May Improve Clinical Outcomes During Hospitalization for Henoch-Schönlein Purpura
2010.10.28
|
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
2010.10.15
|